Home BancShares Posts Q4 EPS $0.60, $282.1M Revenue and $400M Loan Growth
Home BancShares reported Q4 EPS of $0.60 and revenue of $282.1 million, a 9.2% increase and 4.4% beat on loan growth of $400 million, 18% income growth and a sub-40% efficiency ratio. Piper Sandler trimmed its price target to $28 while affirming a soft Buy on improving margins and asset quality.
1. Q4 2025 Financial Results
Home BancShares, Inc. reported fourth-quarter earnings per share of $0.60, matching consensus estimates, and generated revenue of $282.1 million, exceeding the expected $272.5 million. This revenue total represents a 9.2% increase year-over-year and delivered a 4.4% positive surprise versus the consensus estimate of $270.2 million. Net income for the quarter was $118.2 million, reflecting the company’s focus on maintaining strong profitability and operational discipline.
2. Loan Growth and Operational Efficiency
The company achieved loan growth of $400 million during the quarter, contributing to an 18% year-over-year rise in total income. Home BancShares sustained an efficiency ratio below 40%, underscoring disciplined expense management across its 160-branch network. Annualized return on assets reached 2.10%, indicating effective utilization of its asset base, while the resolution of a Texas lawsuit added a one-time boost to the quarter’s bottom line.
3. Balance Sheet Strength and Valuation Metrics
Home BancShares maintains a conservative capital structure, with a debt-to-equity ratio of 0.23 and a current ratio of 0.14. Market valuation metrics include a price-to-earnings ratio of 12.32 and a price-to-sales ratio of 4.13. The enterprise value to sales ratio stands at 4.26, and the enterprise value to operating cash flow ratio is 15.03, reflecting investor confidence in the bank’s cash-flow generation and long-term stability.
4. Analyst Price Target and Outlook
Analysts have modestly reduced their short-term outlook for the shares, with the consensus price target sliding from an average of $31 last month down to $28, as revised by Piper Sandler ahead of the January 14 earnings release. Despite this adjustment, the stock carries a soft "Buy" recommendation, supported by rising net interest margins, revenue growth and asset-quality metrics that surpass industry benchmarks. The company’s next conference call is scheduled for January 15, 2026.